1. Home
  2. ILMN vs TEF Comparison

ILMN vs TEF Comparison

Compare ILMN & TEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • TEF
  • Stock Information
  • Founded
  • ILMN 1998
  • TEF 1924
  • Country
  • ILMN United States
  • TEF Spain
  • Employees
  • ILMN N/A
  • TEF N/A
  • Industry
  • ILMN Medical Specialities
  • TEF Telecommunications Equipment
  • Sector
  • ILMN Health Care
  • TEF Telecommunications
  • Exchange
  • ILMN Nasdaq
  • TEF Nasdaq
  • Market Cap
  • ILMN 22.9B
  • TEF 25.2B
  • IPO Year
  • ILMN 2000
  • TEF 1987
  • Fundamental
  • Price
  • ILMN $142.50
  • TEF $4.46
  • Analyst Decision
  • ILMN Buy
  • TEF
  • Analyst Count
  • ILMN 20
  • TEF 0
  • Target Price
  • ILMN $160.68
  • TEF N/A
  • AVG Volume (30 Days)
  • ILMN 2.2M
  • TEF 851.6K
  • Earning Date
  • ILMN 11-04-2024
  • TEF 11-07-2024
  • Dividend Yield
  • ILMN N/A
  • TEF 7.22%
  • EPS Growth
  • ILMN N/A
  • TEF N/A
  • EPS
  • ILMN N/A
  • TEF N/A
  • Revenue
  • ILMN $4,390,000,000.00
  • TEF $45,249,832,683.00
  • Revenue This Year
  • ILMN N/A
  • TEF $1.62
  • Revenue Next Year
  • ILMN $4.28
  • TEF $0.01
  • P/E Ratio
  • ILMN N/A
  • TEF N/A
  • Revenue Growth
  • ILMN N/A
  • TEF 2.55
  • 52 Week Low
  • ILMN $97.36
  • TEF $3.82
  • 52 Week High
  • ILMN $156.66
  • TEF $4.93
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 50.11
  • TEF 45.90
  • Support Level
  • ILMN $140.56
  • TEF $4.44
  • Resistance Level
  • ILMN $145.37
  • TEF $4.52
  • Average True Range (ATR)
  • ILMN 4.83
  • TEF 0.05
  • MACD
  • ILMN 0.13
  • TEF 0.01
  • Stochastic Oscillator
  • ILMN 77.84
  • TEF 68.75

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About TEF Telefonica SA

Telefonica operates mobile and fixed networks in Spain (where it is the incumbent telephone operator), the UK, Germany, Brazil, and other Latin American countries like Colombia, Mexico, Argentina, and Chile. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.

Share on Social Networks: